Peer Review History

Original SubmissionOctober 17, 2023
Decision Letter - Anselme Shyaka, Editor

PONE-D-23-33609Understanding antibiotic use in the community setting in Thailand: Does communication matter?PLOS ONE

Dear Dr. Sunpuwan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 Please review the suggestions and comments from both reviewers and address the identified concerns. 

Please submit your revised manuscript by Jan 10 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Anselme Shyaka, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: 

Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  

Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. 

Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. Thank you for stating the following financial disclosure: 

"1. The Wellcome Trust , UK 

 2. The Institute for Population and Social Research, Mahidol University, Thailand"

  

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Dr. Malee Sunpuwan,

Thank you for submitting your manuscript for publication by PLOS ONE.

Please find the reviewers’ comments and suggestions for your consideration and appropriate action.

I am looking forward to receiving your revised manuscript.

Sincerely,

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a well-written article. The background information and methods used are clearly described, and the results are interpreted in a way that echoes previous research on the same subject. It's a call for better communication in the dispensing of antibiotics.

However, I have minor comments:

p.2, line 30: In the ‘Objective’ section, it should be written ‘to gain a better understanding of the communication around the use’, and not ‘understanding of the use’. You are basing your interpretations on interviews so you cannot really assess antibiotic use, which would have required observational studies.

p.2, line 48: the term ‘beliefs’ seems inappropriate throughout the paper. No definition is provided, and one gets the impression that the authors talk about misconceptions rather than beliefs. It also seems a little patronizing to talk only about the community members’ beliefs– as if healthcare professionals didn’t have beliefs.

p.11, line 266: the term ‘beliefs’ is unclear. Do you mean ‘representations’ ? Because these ‘beliefs’ can come from previous personal experiences, can they only be ‘beliefs’? I strongly recommend that the authors question the use of the term ‘belief’ throughout the document.

p.4, line 90: ‘actors’ should be written instead of ‘factors’, as the authors seem to be referring mainly to individuals or groups, and not to organisations or other types of factors.

p.6, line 134: How is this sub-study linked to the overall study? We would need more information about this.

p.6, line 145: Data collection was carried out in 2016 and 2017, i.e. 6-7 years from now. Are there any reasons for the delay in publishing the results? This fact should be considered as a limitation, as the context may have changed somewhat since then. It would be important for the authors to take this into account in their article.

Methods

p.8, line 185: No private clinics were recruited in the 2nd phase. Why was this?

p.9, line 202: Why was random sampling used to recruit community members? Given the small sample size, other strategies such as snowball sampling with clear selection criteria could have been used. What is the reasoning behind this approach?

p.9, line220: FGD, could you explain a little bit more what you mean by ‘recruited through the community network’?

Study procedures

p.10, line 234: Where did the FGD take place?

Data analysis

p.10, line 242: After the recordings were transcribed, were they translated into English for coding, or was the analysis done in Thai?

Theme 3

p.17, line 415-416: To discuss the link between people’s “beliefs” and their practices regarding the use of antibiotics as being solely causal is rather simplistic and reductive. The influence of a person’s beliefs on their practices is not so simple; other factors may come into play. In the sentence line 416-417 “Antibiotic practices are influenced by individuals’ beliefs”, I should mention that these “beliefs” are not the only factors.

When the participants talk about their fear of side effects and interaction with other medications they are taking, we (as researchers or health professionals) need to take this seriously. These are legitimate concerns we need to listen to, and not some ‘beliefs’ we have to get rid of. If we deny people’s concerns and needs, we will continue to reproduce a very authoritarian and biomedical way of thinking about antibiotic use.

p.21, line 500: what do you mean by ‘at the village level’? It doesn’t seem very clear to me.

p.24, line 527: In this sentence, the example does not refer to a ‘belief’ but rather to the fact that users were not given access to the information they needed, which is quite different from what you write. I recommend changing this sentence.

Reviewer #2: Thanks for an interesting and well-written manuscript, very well done!

I would suggest changing the word “authoritative” in the abstract (line 54) as it seems like a rather “top-down” approach to change behaviors in relation to antibiotic use.

Even though you have attached a document (S2 File), explaining the different healthcare service levels (tertiary, secondary and primary), I would suggest that you include a brief description about this (like 1-2 sentences) in the article to improve readability.

It would be helpful if you could provide some additional information in the text about the community; how do people generally live, occupation, class (rich, poor etc.?), general access to services? In relation to your suggestion on line 496 about QR codes, do people in rural areas typically own a smart phone, for example?

You mention “power” several times in the article, but without providing a clear definition or any references to other scholars that engage with concepts of power. As there are numerous definitions of power in the wider social sciences literature, please include a brief definition of power in the article.

I have highlighted a few sentences/words in the paper that I found difficult to follow, where I would suggest some editing for improved readability.

Please add a reference on line 533 as you have previously stated that: “The literature reveals that access to power and resources is negotiated in everyday life”. What specific literature do you refer to here?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: Manuscript comments reviewer.pdf
Revision 1

January 17, 2024

Anselme Shyaka

Academic Editor

PLoS ONE

Dear editor,

We appreciate the opportunity to resubmit our revised manuscript and would like to extend our gratitude to both you and the reviewers for their positive feedback and constructive comments. We have carefully considered and incorporated the suggested corrections and modifications, and we are delighted to resubmit our manuscript for further consideration.

In response to the detailed suggestions provided by you and the reviewers, we have made significant edits aimed at addressing all identified issues and concerns. The point-by-point response to the questions and comments is outlined at the end of this letter to assist in the review of our revisions.

We would like to express our sincere thanks for the invaluable comments and queries that have allowed us to strengthen our manuscript. We have diligently worked to incorporate your feedback, and we hope that these revisions demonstrate our commitment to improving the quality of our submission.

Thank you once again for this opportunity, and we look forward to the possibility of our manuscript being accepted for publication.

Sincerely yours,

Malee Sunpuwan

(Malee Sunpuwan)

Corresponding author

malee.sun@mahidol.ac.th

+662 4410201 ext.604

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

RESPONSE: Thank you for this suggestion. Our manuscript has been prepared in accordance with the provided guidelines.

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS:

Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

RESPONSE: Thank you for sharing this valuable information! We were not aware of the significant citation advantage associated with depositing data in a repository. We will definitely consider this for our future work to ensure broader visibility and impact. The idea of earning an Accessible Data icon on published papers is intriguing too.

3. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.

Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting.

Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

RESPONSE: Thank you very much for this information. We have completed the questionnaire on inclusivity in global research and attached it as a supporting file.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

RESPONSE: Thank you for this suggestion. We have provided the grant numbers as follows: 219403/Z/19/Z.

5. Thank you for stating the following financial disclosure:

"1. The Wellcome Trust , UK

2. The Institute for Population and Social Research, Mahidol University, Thailand"

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf

RESPONSE: Thank you for this suggestion. We have stated that "The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript."

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

RESPONSE: Thank you for the suggestion. We have included captions for Supporting Information files at the end of the manuscript and updated in-text citations, as well as references, to match accordingly.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

RESPONSE: Thank you for your suggestion. We have confirmed that none of the papers in our references have been retracted. To verify this information, we utilized the Zotero program, integrated with the Retraction Watch Database. Additionally, we have included some references to support the definition of power and its related studies

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a well-written article. The background information and methods used are clearly described, and the results are interpreted in a way that echoes previous research on the same subject. It's a call for better communication in the dispensing of antibiotics.

However, I have minor comments:

p.2, line 30: In the ‘Objective’ section, it should be written ‘to gain a better understanding of the communication around the use’, and not ‘understanding of the use’. You are basing your interpretations on interviews so you cannot really assess antibiotic use, which would have required observational studies.

RESPONSE: We appreciate your suggestion, and we agree with it. We have modified the objective to read: 'This study aims to gain a deeper understanding of communication around the use of antibiotics in the community and seeks potential implementation strategies to change dispensers' and users' practices in communication aspects' (see line 29)

p.2, line 48: the term ‘beliefs’ seems inappropriate throughout the paper. No definition is provided, and one gets the impression that the authors talk about misconceptions rather than beliefs. It also seems a little patronizing to talk only about the community members’ beliefs– as if healthcare professionals didn’t have beliefs.

RESPONSE: Thank you for this suggestion; we agree to use 'misconceptions' instead of 'beliefs' throughout the manuscript when appropriate.

p.11, line 266: the term ‘beliefs’ is unclear. Do you mean ‘representations’ ? Because these ‘beliefs’ can come from previous personal experiences, can they only be ‘beliefs’? I strongly recommend that the authors question the use of the term ‘belief’ throughout the document.

RESPONSE:Thank you for this suggestion; we have concurred with it and have opted to use 'misconceptions' instead of 'beliefs

p.4, line 90: ‘actors’ should be written instead of ‘factors’, as the authors seem to be referring mainly to individuals or groups, and not to organisations or other types of factors.

RESPONSE: Thank you for this suggestion; we have agreed and used 'actors' instead of 'factors (see lines 83)

p.6, line 134: How is this sub-study linked to the overall study? We would need more information about this.

RESPONSE: Thank you for this suggestion; we have added more information on how this sub-study is connected to the overall study. "and consumption, as well as the underlying factors, in six countries across Africa and Asia. Additionally, the project aims to systematically investigate understandings of antibiotic use, along with related health-seeking behaviors and the broader contextual factors influencing these behaviors. As this sub-study is conducted in Thailand, an upper-middle-income country in Asia, it contributes to a better understanding of antibiotic usage". (see lines 138-140).

p.6, line 145: Data collection was carried out in 2016 and 2017, i.e. 6-7 years from now. Are there any reasons for the delay in publishing the results? This fact should be considered as a limitation, as the context may have changed somewhat since then. It would be important for the authors to take this into account in their article.

RESPONSE: Thank you for this suggestion; we have taken it into consideration and included more information on limitations (see lines 636-637). The reason for the delay is that we continued our research on ongoing issues until 2022, and communication challenges persisted during the latest phase of the study (ABACUS II). However, it was not the primary focus then, so we decided to utilize data from ABACUS I.

Methods

p.8, line 185: No private clinics were recruited in the 2nd phase. Why was this?

RESPONSE: Thank you for this comment, we appreciate your comment and have taken it into consideration. We have now included additional information explaining the reasons for not recruiting private clinics in the second phase. Specifically, the explanation states, 'However, since the second phase involved following up on the issues identified in the first phase with the same drug suppliers, the two private clinics declined to participate in this phase (see lines 189-191)

p.9, line 202: Why was random sampling used to recruit community members? Given the small sample size, other strategies such as snowball sampling with clear selection criteria could have been used. What is the reasoning behind this approach?

RESPONSE: Thank you for this question. Since this is the sub-study and one of its objective is to compare across sites in six LMICs we have added the information to make it clear “The selection of community members was made randomly from the HDSS database, which aimed to use standardized methods for studying antibiotic use in six LMICs. This reflected the full geographical range of the site” (see line 207-210).

p.9, line220: FGD, could you explain a little bit more what you mean by ‘recruited through the community network’?

RESPONSE: Thank you; we have added more information to clarify 'recruited through the community network’ by including the following: 'Participants were recruited through the community network, which involved collaboration between the research team and community members in the study areas.” (see lines 226-228).

Study procedures

p.10, line 234: Where did the FGD take place?

RESPONSE: Thank you for this question; we added information on places of conducting IDIs and FGDs 'IDIs were conducted at participants’ houses, clinics, and workplaces, while FGDs were conducted at community canters such as community halls, meeting rooms, pavilions, and temples located in the study areas” (see lines 241-243).

Data analysis

p.10, line 242: After the recordings were transcribed, were they translated into English for coding, or was the analysis done in Thai?

RESPONSE: Thank you for this question. The audio transcription was done in Thai to facilitate data analysis, and the analysis itself was also carried out in Thai (see lines 251-252).

Theme 3

p.17, line 415-416: To discuss the link between people’s “beliefs” and their practices regarding the use of antibiotics as being solely causal is rather simplistic and reductive. The influence of a person’s beliefs on their practices is not so simple; other factors may come into play. In the sentence line 416-417 “Antibiotic practices are influenced by individuals’ beliefs”, I should mention that these “beliefs” are not the only factors.

RESPONSE: Thank you for this point. We agreed that it is not only one factor but also other factors, and we have changed it to. “Although antibiotic practices are influenced by several factors, individuals' misconceptions are one of such factor that affects whether they choose to follow the provided instructions or not.” (see lines 434-437)

When the participants talk about their fear of side effects and interaction with other medications they are taking, we (as researchers or health professionals) need to take this seriously. These are legitimate concerns we need to listen to, and not some ‘beliefs’ we have to get rid of. If we deny people’s concerns and needs, we will continue to reproduce a very authoritarian and biomedical way of thinking about antibiotic use.

RESPONSE: Thank you for this concern. We have considered this suggestion and added more information in the discussion section: 'Nevertheless, concerns about side effects are legitimate, and healthcare personnel should listen and respond with empathy and professionalism. This empathetic communication is crucial (see lines 614-616)

p.21, line 500: what do you mean by ‘at the village level’? It doesn’t seem very clear to me.

RESPONSE: Thank you for raising this question. To provide clarity, we have revised it to say, 'This shows how ingrained this practice is in the community. (see line 460).

p.24, line 527: In this sentence, the example does not refer to a ‘belief’ but rather to the fact that users were not given access to the information they needed, which is quite different from what you write. I recommend changing this sentence.

RESPONSE: Thank you for this suggestion. We have modified the sentence from 'This belief discourages compliance and is a primary reason for the lack of adherence' to 'This lack of complete information and communication discourages compliance and is a primary reason for the lack of adherence' (see line 596-597)

Reviewer #2: Thanks for an interesting and well-written manuscript, very well done!

I would suggest changing the word “authoritative” in the abstract (line 54) as it seems like a rather “top-down” approach to change behaviors in relation to antibiotic use.

RESPONSE: Thank you for this suggestion. We agreed and have replaced the word 'authoritative' with 'trustworthy”. (line 53)

Even though you have attached a document (S2 File), explaining the different healthcare service levels (tertiary, secondary and primary), I would suggest that you include a brief description about this (like 1-2 sentences) in the article to improve readability.

RESPONSE: Thank you; we have included a brief description: 'Thailand's healthcare system comprises three levels—primary (sub-district health-promoting hospitals), secondary (district, provincial, and regional hospitals), and tertiary (university and large private hospitals). Both public and private sectors play vital roles, with public facilities serving about three-fourths of the population. Informal healthcare providers, such as pharmacies and traditional healers, also contribute to the healthcare landscape (more details in S2 File).' (see lines 164-169)"

It would be helpful if you could provide some additional information in the text about the community; how do people generally live, occupation, class (rich, poor etc.?), general access to services? In relation to your suggestion on line 496 about QR codes, do people in rural areas typically own a smart phone, for example?

RESPONSE: Thank you for this suggestion. We have incorporated more information about community characteristics. For instance, "A majority of them, almost two-thirds or 60%, are involved in sales and service, working for wages, and living in non-poor households. All have access to health services under universal healthcare" (see lines 266-268).

Additionally, we have included more statistics about smartphone ownership among migrants and the overall population in Thailand and the study areas (see lines 517-519, 529-531).

You mention “power” several times in the article, but without providing a clear definition or any references to other scholars that engage with concepts of power. As there are numerous definitions of power in the wider social sciences literature, please include a brief definition of power in the article.

RESPONSE: Thank you; we have defined it. In our study, power is described as the ability to influence actions, encompassing both 'power over' and 'power to.' 'Power over' denotes control over decision-making, resources, ideas, and meanings, while 'power to' relates to an individual's ability to take action” (see lines 276-279). Additionally, we have added more information related to the definition of power and related literature in the discussion part (see lines 553-571)."

I have highlighted a few sentences/words in the paper that I found difficult to follow, where I would suggest some editing for improved readability.

RESPONSE: Thank you for the suggestion. We have sent the manuscript to a professional editing and proofreading service. Please find attached the certificate of editing and proofreading.

Please add a reference on line 533 as you have previously stated that: “The literature reveals that access to power and resources is negotiated in everyday life”. What specific literature do you refer to here?

RESPONSE: Thank you for your careful review. We have cited the following reference:

Ekström M, Stevanovic M. Conversation analysis and power: examining the descendants and antecedents of social action. Frontiers in Sociology. 2023;8:1196672.

________________________________________

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

________________________________________

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

________________________________________

In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Remove my information/details). Please contact the publication office if you have any questions.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Anselme Shyaka, Editor

Understanding antibiotic use in the community setting in Thailand: Does communication matter?

PONE-D-23-33609R1

Dear Dr. Sunpuwan,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Anselme Shyaka, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Anselme Shyaka, Editor

PONE-D-23-33609R1

PLOS ONE

Dear Dr. Sunpuwan,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Anselme Shyaka

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .